A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report

Sho Ishiwa(National Center For Child Health and Development), Satoshi Narumi(National Center For Child Health and Development), Ichiro Takeuchi(Juntendo University), Kanako Tanase‐Nakao(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Koichi Kamei(National Center For Child Health and Development), Shinsuke Shibata(Keio University), Mai Sato(Kyoto University), Kunihiro Matsunami(Gifu Prefectural General Medical Center)
BMC Nephrology
August 12, 2020
10.1186/s12882-020-02011-4
Cited by 18

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135